McGowan Institute for Regenerative Medicine faculty member William J. Federspiel, PhD, the University of Pittsburgh's William Kepler Whiteford Professor of Chemical Engineering, Surgery and Bioengineering, and Director of the McGowan Institute’s Medical Devices Laboratory, oversees current laboratory research that is tackling fundamental problems associated with making artificial lungs more efficient and biocompatible, and is developing next generation artificial lungs or blood oxygenators. Dr. Federspiel is also a Founder of ALung Technologies, Inc., a Pittsburgh-based medical start-up company, for which he currently serves as Chief Scientific Officer. ALung is the leading developer of a device—the Hemolung System—designed to replace or supplement ventilators in hospitals. Soon, clinical trials in Indian and German will begin on the Hemolung System which is expected to positively impact clinical outcomes and reduce the length of hospital stays by several days, resulting in a significant reduction of total medical costs for providers and insurers.
- Clinical Trials to Begin on Respiratory Support Medical Device
- Dr. Michael Boninger Named Chair of Physical Medicine and Rehabilitation Department
- Intestinal and Multivisceral Transplant Survival Rates Improve Using Novel Treatment
- Pitt’s School of Engineering Board of Visitor’s Faculty Award Winner: Dr. Steven Little
- Dr. Eric Lagasse Receives 2009 NIH Director's Transformative R01 Award
- Wheelchair’s Robotic Arms Controlled Remotely via the Internet
- Ipsita Banerjee Awarded NIH Director’s New Innovator Award
- William Federspiel Named New Graduate Coordinator
- Alternative Cells for Regenerative Medicine
- At the Right Place, At the Right Time
- See In the News Archive and Search Feature